Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.

Allergy and asthma proceedings - 1 Nov 2021

Ptasinski Anna, Colello Jacob, Ptasinski Joseph, Barclay Gavin, Craig Timothy

Abstract excerpt

Background: Alpha-1-antitrypsin deficiency (AATD) is an orphan disease that mainly affecting the liver and the lung. This creates difficulties to ensure that comprehensive care is administered to both organ systems. Past assessments of care delivered to patients with AATD demonstrated that improvements are needed. For that reason, we reassessed a population of patients with AATD in a large health care system to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha 1-Antitrypsin
Share to alpha 1-Antitrypsin Deficiency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Genotype

Share to Pulmonary Disease, Chronic Obstructive

Share to Surveys and Questionnaires

Source

Open in PubMed Open full text

Identifiers

PMID: 34871162
DOI: 10.2500/aap.2021.42.210067
PMCID: PMC8654386

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.PMID 34871162Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.Semantic proximity Read ↗

Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden.Semantic proximity Read ↗

Understanding alpha-1 antitrypsin deficiency: A review with an allergist's outlookSemantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

Trends in Diagnosis of Alpha-1 Antitrypsin Deficiency Between 2015 and 2019 in a Reference Laboratory.Semantic proximity Read ↗

Diagnosing α1-antitrypsin deficiency: how to improve the current algorithm.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicineSemantic proximity Read ↗

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil.Semantic proximity Read ↗

Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.Semantic proximity Read ↗

Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.